Instadose Pharma Corp
OTC:INSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
One Swiss Bank SA
SIX:ONE
|
CH |
|
Lvji Technology Holdings Inc
HKEX:1745
|
CN |
|
P
|
Pentamaster Corporation Bhd
KLSE:PENTA
|
MY |
|
D
|
Desun Real Estate Investment Services Group Co Ltd
HKEX:2270
|
CN |
|
I
|
IWS Group Holdings Ltd
HKEX:6663
|
HK |
|
J Trust Co Ltd
TSE:8508
|
JP |
|
K
|
Keep Inc
HKEX:3650
|
CN |
Instadose Pharma Corp
Instadose Pharma Corp. engages in the designing, manufacturing and selling of micro-furniture that transforms any small space, particularly apartments and condominiums into functional spaces. The company is headquartered in Chesapeake, Virginia. The company went IPO on 2019-03-07. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canada’s Global Distribution Platform spans five (5) continent, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include Organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation Participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies; and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents. Its subsidiaries include Instadose Pharma, LDA and Instadose Pharma, LDA.
Instadose Pharma Corp. engages in the designing, manufacturing and selling of micro-furniture that transforms any small space, particularly apartments and condominiums into functional spaces. The company is headquartered in Chesapeake, Virginia. The company went IPO on 2019-03-07. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canada’s Global Distribution Platform spans five (5) continent, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include Organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation Participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies; and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents. Its subsidiaries include Instadose Pharma, LDA and Instadose Pharma, LDA.
